Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2008 4
2009 5
2010 1
2011 2
2012 2
2013 1
2014 3
2015 3
2019 2
2020 3
2021 4
2022 3
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Dapagliflozin in Patients with Chronic Kidney Disease.
Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjöström CD, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24. N Engl J Med. 2020. PMID: 32970396 Free article. Clinical Trial.
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
Heerspink HJL, Cherney D, Postmus D, Stefánsson BV, Chertow GM, Dwyer JP, Greene T, Kosiborod M, Langkilde AM, McMurray JJV, Correa-Rotter R, Rossing P, Sjöström CD, Toto RD, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. Kidney Int. 2022 Jan;101(1):174-184. doi: 10.1016/j.kint.2021.09.005. Epub 2021 Sep 22. Kidney Int. 2022. PMID: 34560136 Free article. Clinical Trial.
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
Heerspink HJL, Sjöström CD, Jongs N, Chertow GM, Kosiborod M, Hou FF, McMurray JJV, Rossing P, Correa-Rotter R, Kurlyandskaya R, Stefansson BV, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. Eur Heart J. 2021 Mar 31;42(13):1216-1227. doi: 10.1093/eurheartj/ehab094. Eur Heart J. 2021. PMID: 33792669 Free PMC article. Clinical Trial.
Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis.
Martín-Carro B, Navarro-González JF, Ortiz A, Zoccali C, Floege J, Ferreira MA, Gorriz-Teruel JL, Carrillo-López N, Panizo S, Locatelli F, Ketteler M, London GM, Naves-Díaz M, Alonso-Montes C, Cannata-Andía JB, Fernández-Martín JL. Martín-Carro B, et al. Among authors: gorriz teruel jl. Nephrol Dial Transplant. 2023 Oct 31;38(11):2589-2597. doi: 10.1093/ndt/gfad122. Nephrol Dial Transplant. 2023. PMID: 37349949 Free PMC article.
Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients.
Barrera-Baena P, Rodríguez-García M, Rodríguez-Rubio E, González-Llorente L, Ortiz A, Zoccali C, Locatelli F, Floege J, Cohen-Solal M, Ferreira MA, Ketteler M, London GM, Gorriz-Teruel JL, Sánchez-Álvarez E, Hevia-Suárez MÁ, Fernández-Gómez JM, Martín-Carro B, Gómez-Alonso C, Alonso-Montes C, Cannata-Andía JB, Fernández-Martín JL; COSMOS. Barrera-Baena P, et al. Among authors: gorriz teruel jl. Nephrol Dial Transplant. 2024 Mar 27;39(4):618-626. doi: 10.1093/ndt/gfad190. Nephrol Dial Transplant. 2024. PMID: 37660283 Free PMC article.
Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes.
Castro Conde A, Marzal Martín D, Campuzano Ruiz R, Fernández Olmo MR, Morillas Ariño C, Gómez Doblas JJ, Gorriz Teruel JL, Mazón Ramos P, García-Moll Marimon X, Soler Romeo MJ, León Jiménez D, Arrarte Esteban V, Obaya Rebollar JC, Escobar Cervantes C, Gorgojo Martínez JJ. Castro Conde A, et al. Among authors: gorriz teruel jl. J Clin Med. 2023 Jun 8;12(12):3925. doi: 10.3390/jcm12123925. J Clin Med. 2023. PMID: 37373620 Free PMC article. Review.
Optimizing the timing of nephrology referral for patients with diabetic kidney disease.
Martínez-Castelao A, Soler MJ, Górriz Teruel JL, Navarro-González JF, Fernandez-Fernandez B, de Alvaro Moreno F, Ortiz A. Martínez-Castelao A, et al. Among authors: gorriz teruel jl. Clin Kidney J. 2020 Aug 5;14(1):5-8. doi: 10.1093/ckj/sfaa125. eCollection 2021 Jan. Clin Kidney J. 2020. PMID: 33564400 Free PMC article.
[Considerations for ezetimibe and renal impairment].
Pallarés-Carratalá V, Vizcaíno-Castillo B, Górriz-Teruel JL. Pallarés-Carratalá V, et al. Among authors: gorriz teruel jl. Aten Primaria. 2015 Jun-Jul;47(6):388-9. doi: 10.1016/j.aprim.2014.07.011. Epub 2014 Nov 15. Aten Primaria. 2015. PMID: 25454850 Free PMC article. Spanish. No abstract available.
Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review.
Ruiz-García A, Pallarés-Carratalá V, Serrano-Cumplido A, Escobar-Cervantes C, Barquilla-García A, Divisón-Garrote JA, Turégano-Yedro M, Prieto-Díaz MA, Cinza-Sanjurjo S, Alonso-Moreno FJ, Beato-Fernández P, García-Matarín L, Rey-Aldana D, Martín-Rioboó E, Moyá-Amengual A, Crespo-Sabarís R, Piera-Carbonell A, Romero-Vigara JC, Carrasco-Carrasco E, Velilla-Zancada S, Seoane-Vicente MC, Górriz-Teruel JL, Polo-García J, Barrios V; SEMERGEN Working Group on Hypertension, Cardiovascular Disease. Ruiz-García A, et al. Among authors: gorriz teruel jl. Semergen. 2022 May-Jun;48(4):275-292. doi: 10.1016/j.semerg.2021.12.002. Epub 2022 Feb 15. Semergen. 2022. PMID: 35181226 Review.
34 results